Topic Date Question Answer
Governance, Risk Management & Use
Actuarial Function The plan shows the review of the Actuarial Function late in the process - does Lloyd's consider this appropriate? The Actuarial Function is a good example of an area that whilst sitting in the Governance, Risk Management and Use workstream, will
also be considered as part of other workstreams (e.g.. Technical Provisions). As such the specifics of certain elements of this review
Mar-11 will be considered across a number of workshops and documentation requests and all review work will not be left until Q3 2011.
Actuarial Function If a managing agent has its Actuarial Function completely outsourced, can it still be Solvency II compliant? Yes, however, there needs to be clear evidence of compliance and the requirements for the Actuarial Function could make this
onerous. For example: The Actuarial Function must “contribute to the effective implementation of the risk-management system referred to in
Article 44, in particular with respect to the risk modelling underlying the calculation of the capital requirements”. This extends the requirement
beyond calculating the technical provisions and the requirement will need to see links to active contribution to the risk management
system of a syndicate and the capital modelling. There is more emphasis on the Actuarial function to assess the suitability and quality
of data. This will extend beyond receiving a Data Accuracy Statement and syndicate will need to evidence how an external party will be
satisfying the requirements surrounding data management. The requirements surrounding outsourcing introduced as part of Solvency
II will also need to be satisfied.
Contingency Plans What is Lloyd's contingency plan in the event that the Internal Model is not approved? Lloyd's is currently undertaking discussions at steering group level on the outcomes and actions required should the model not be
approved - this includes both syndicate models and the LIM. These discussions are ongoing internally and will also be discussed with
the FSA. Agents should have contingency plans in place to deal with the situation where a syndicate model is not approved.
Evidence Templates Are agents required to complete the greyed out use test tab on the evidence template? In the use test template we require agents to complete only the cells in the lines which are not greyed out - i.e. the 9 principles of the
Use Test (rows 6,10,13,18,21,25,29,32 & 36). Under each of these principles we have greyed out the underlying rows of detail points
Mar-11 below which provide more detail around the principle but where we would not necessarily expect separate evidence.
Agents should, however, bear these principles in mind when completing the evidence templates. Whilst they are not expected to be
evidenced separately, Lloyd's will look for application of the principles when assessing the quality of evidence in other areas.
Information Systems Could Lloyd’s provide more guidance around the requirement regarding “Adequacy of Information Systems”. What should the content of documentation in relation to this The evidence templates purposely only set out the CEIOPS requirements as we want to understand how agents think they meet each
information systems that produce sufficient, reliable, consistent, timely and relevant
be? CEIOPS guidance is very vague: "Establish of the requirements. As part of the dry run review in 2010, the sort of evidence we thought may be available was: IT systems review
information concerning all business activities, the commitments assumed and the risks to which the undertaking is exposed." documentation i.e. gap analysis of their systems against the needs of Solvency II, Information and data security policy statement, Data
security review documentation, Data accuracy reporting, Management information produced on the back of the above etc. This is also
linked to the Adequacy of records and security information requirement. Taken together, agents need to be considering the questions:
Is the data we are using correct? Are we using the correct data in terms of MI etc?
Model Change Policy How is Lloyd's planning to define the model change policy? Specification of major and minor changes will include consideration of various types of model change (e.g. changes in governance or
external models), as well as the criteria for classifying changes as major or minor. A number of criteria are being considered, including
quantitative aspects such as the effect of any change on the SCR as well as consideration of other factors such as methodology
Model Change Policy Internal model change policy - how will this work after 'live' with 2 regulators - will we get conflicting messages? We would expect that Lloyd's will have primary responsibility for assessing material changes with the FSA monitoring our review work
and the impact on the overall LIM change policy.
Non-Executive Directors What is Lloyd's doing to ensure that Non-executive directors have a better understanding and spend appropriate time considering Lloyd's will hold board level briefings on Solvency II for both executive directors and NEDs in May, August and November. Those will
Solvency II? highlight areas where the board should be challenging their Solvency II programme as well as producing updates on general market
Mar-11 progress and issues. However, agents should take responsibility for ensuring that their own NEDs are fully briefed and informed on
Solvency II issues and that they spend sufficient time on a formal process for this [link to FSA slides].
ORSA Can agents submit a Group ORSA or must it be by syndicate? Lloyd's will require an ORSA to contain syndicate specific information and as such will require the agent to submit an ORSA for each
Feb-11 managed syndicate.
ORSA Will more guidance be available from Lloyd's on the ORSA process, and in particular, how do syndicate ORSAs interact with the Lloyd's will issue further guidance on the ORSA process later in 2011. Following feedback from the draft plan document, the ORSA
Lloyd's ORSA? workshop has been brought forward to earlier in the year to allow greater preparation time prior to submission. At present, Lloyd's does
Mar-11 not expect there to be a formal direct link from syndicate ORSAs to society ORSA and Lloyd's will continue to set economic (and
member level) capital using an agreed basis.
ORSA Reports There is no mention of ORSA in the Evidence and Timing document. As agents will be developing their ORSA reports throughout the The ORSA submission date is 16 December. Lloyd's will aim to provide as much guidance ahead of this date as possible and will be
Mar-11 year, will there be an opportunity of any review from Lloyd's of iterations before the December deadline? happy to discuss specific elements with managing agents at any time throughout 2011. However, there will be no formal review
process ahead of the December submission.
Outsourcing Is there an update on the implications of treating delegated underwriting arrangements as outsourcing? Lloyd's expectation is that EIOPA will resolve that delegated underwriting will constitute outsourcing. Lloyd's have been conducting a
May-11 review of how this will impact current binding authority and coverholder arrangements and associated documentation. Additional
guidance on the practical implications of this will be issued to the market later in 2011.
Outsourcing/Delegated Underwriting Will delegated underwriting be classed as outsourcing and when will more information on this be available? In the latest Level 3 pre-consultation guidance it is clear that delegated underwriting will be classed as an outsourced activity. Lloyd's
Mar-11 and the LMA are undertaking work in this area to fully understand the potential impact. Lloyd’s will be able to provide more information
on the impact in Q2 2011.
Outsourcing/Third Party Administrators The deadline for outsourcing self-assessment review programme is due on March 21st when further clarity on TPAs is not due until The review activity will only be undertaken against the existing guidance. Should further guidance be issued later in the year which has
Mar-11 the end of March - is this appropriate?. a material impact on the approach, the specific activity to update this review will be published at that time.
Outsourcing/Xchanging With regards to the role of Xchanging in outsourcing, has there been any progress in taking this forward centrally? Is there a central The main oversight of Xchanging currently sits with the LMA, however Lloyd’s are looking to provide more central oversight and will be
oversight for the policy? working with the LMA on the overall approach to this.
Reliance on Lloyd's Process Do the processes carried out centrally by Lloyd's on business planning and controls need to be repeated by the syndicates? It will be necessary to evidence how the syndicate meets the Solvency II requirements whether through their own processes or reliance
Mar-11 on a Lloyd's central process. Where a Lloyd's process is relied upon, we do not envisage that the agent would need to replicate this
process within their own documentation, a reference to the Lloyd's process should suffice.
Risk Aggregation With reference to the risk appetite examples provided at the workshop, how could these be linked into an aggregated risk appetite The examples provided are intended as an illustration of one way in which risk appetite could be expressed and monitored. Lloyd's
May-11 statement? would not expect to see a mathematical aggregation of these illustrative measures to derive an overall risk appetite statement, but
would expect some consideration of higher level appetite statement(s) within the overall framework and the consideration of key metrics
at an appropriate level within the organisation.
Topic Date Question Answer
Risk Appetite Does Lloyd's have an overarching risk appetite statement? No, there are 14 high level statements which are broken down into various metrics and monitored by the Franchise Board. Agents will
need a framework for risk appetite that fits their own circumstances and a top level statement of risk appetite may be an important
feature of this. Whatever framework is adopted, it will be important to ensure that board members can articulate how the board montors
risk appetite, including any top level statement(s) and more detailed metrics which support this.
Risk Appetite What has Lloyd’s approach been to Risk Appetite and how have they balanced the “top-down” and “bottom-up” approaches? Lloyd’s now has a set of risk appetite statements which have been approved by the Franchise Board. This consists of 14 measures
which the Franchise Board regard as fundamental. These are split into 2 categories; 6 for the Corporation and 8 for the Market. They
Mar-11 are all quite high level e.g.. Cat Risk, Reserve Risk, Central Fund Reserve Risk, consisting of a simple statement and one or two
metrics. Lloyd’s task now is to implement the reporting and MI around these items. The items will change over time so they need to be
under continual review.
Use Test Do agents need to look at a comprehensive list of uses? Ultimately agents will need to be able to provide evidence of their identified business uses operating in practice. It is likely that any
process to agree uses will initially identify a more extensive set of possible uses which will be narrowed down. This was the case for
Lloyd's, where the process described in the workshop slides initially identified a more extensive set of uses, which has been prioritised
to focus on a more manageable number. Any list of uses should not be considered as static, ideally there should be a regular (possibly
annual) review of the list to identify any new uses arising as the business model changes. It may be that the use test approach will be
developed to include some of the lower priority uses over time.
Use Test What is the process for the demonstrating the Use Test and how might this apply specifically to run-off syndicates? A logical process would be to agree the key uses and then document the uses that are fundamental to decision making. This approach
Mar-11 would be applicable to all syndicates even though the key uses will vary.
Use Test What is Lloyd's expecting to see as evidence for the Use Test? The evidence provided will vary from agent to agent and will depend on what has been determined by each agent to be a key use.
From the review activity being undertaken, Lloyd's will get appropriate information on the level of embeddedness within the business
Mar-11 and expect agents to be able to demonstrate this. Should specific evidence be required this will be flagged to the market as soon as it
has been determined.